HEMOPHILIA A

DBT & CSCR executes India’s first Human Gene Therapy for Hemophilia A patients

In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with the production of Factor VIII for a prolonged period of time thus obviating the need for repeated infusions.